NR4A1 and breast cancer: Breast cancer endocrine therapy has transformed from a relatively obscure treatment option to a cornerstone of breast cancer management over the past few decades (7–9), which has been fueled by the deepened understanding of the hormone receptor status in breast cancer cells (10, 11).